EUVIMEDEUVIMED entdecken
Open Access

Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection

Marla J Keller, Tao Wang, Kerry Murphy, Myrna G Serrano iD, William Kandalaft, Ian Michael iD, Glenn Decety, Jessica McWalters, Greg A Buck iD, Libusha Kelly, Betsy C Herold iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Marla J Keller und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, HIV Infections, Vagina, Cervix Uteri. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacterial vaginosis (BV) is a major health problem associated with increased HIV risk. To explore underlying mechanisms, we assessed the cervicovaginal mucosal immune environment before and after metronidazole treatment in women with BV and healthy controls.

Methods

Women with BV diagnosed clinically by Amsel criteria were treated with oral or intravaginal metronidazole. Vaginal swabs and cervicovaginal lavage (CVL) were obtained at enrollment and approximately 2 and 4 weeks later for assessment of immune mediators, antiviral activity, and 16-second rRNA gene sequencing. Healthy controls had sampling at enrollment and 4 weeks.

Results

Vaginal pH, Nugent score, Shannon diversity index, and vaginal community state types differed significantly at enrollment between women with clinical BV (n = 19) and controls (n = 13, P < .001). BV cases had significantly higher CVL IL-1α and TNF-α but lower IgG at enrollment as compared with controls, which improved following treatment. Similar results were observed if participants with discordant molecular results (n = 3) were excluded. Most notably, CVL from BV cases enhanced, whereas control CVL inhibited, HIV infection of cells relative to buffer (mean ± SD, 138.4% ± 109.8% vs 30.9% ± 37.9%; P = .001). There was a transient reduction in HIV enhancement following treatment, which was not sustained. Enhancement correlated with community state types and markers of dysbiosis. Specifically, decreases in lactobacilli and increases in Prevotella, Dialister micraerophilus, and Peptoniphilus lacrimalis were associated with enhancement.

Conclusions

These findings provide a potential mechanistic link that may contribute to the increased risk of HIV in association with BV, and they highlight the importance of early diagnosis and improved treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaginosis, BacterialHIV InfectionsVaginaCervix UteriHumansFemaleAdultYoung AdultMetronidazoleMicrobiota

Stichwörter der Autor:innen

HIVbacterial vaginosismucosal immunityvaginal microbiome

Substanzen

Metronidazole

Autor:innen und Institutionen

  • Department of Medicine.
  • Department of Epidemiology and Population Health.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
  • Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond.
  • Department of Systems and Computational Biology.
  • Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York.

ORCID-Profile: Myrna G Serrano, Ian Michael, Greg A Buck, Betsy C Herold

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS
  • National Institute of Child Health and Human Development, National Institute of Allergy and Infectious Diseases
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Keller, M. J., Wang, T., Murphy, K., Serrano, M. G., Kandalaft, W., Michael, I., Decety, G., McWalters, J., Buck, G. A., Kelly, L., & Herold, B. C. (2025). Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf444

Vancouver

Keller MJ, Wang T, Murphy K, Serrano MG, Kandalaft W, Michael I, et al. Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf444

BibTeX
@article{Keller2025,
  author = {Keller, Marla J and Wang, Tao and Murphy, Kerry and Serrano, Myrna G and Kandalaft, William and Michael, Ian and Decety, Glenn and McWalters, Jessica and Buck, Greg A and Kelly, Libusha and Herold, Betsy C},
  title = {Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf444}
}
Kostenlos starten →